Please assess the completion status of the following clinical trial:

Trial Title: Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed severe hypertension~Exclusion Criteria:~* Inability to discontinue all prior antihypertensive medications~* Heart failure of any kind~* History of stroke, transient ischemic attack, myocardial infarction, chest pain, abnormal heart rhythm Liver, kidney, or pancreas disease~* Diabetes with poor glucose control~* Allergy to certain medications used to treat high blood pressure~Other protocol-defined exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).